Methodology: 3/5
Usefulness: 3/5

Luo Z,  et al. JAMA. 2024;332(20):1709–1722. doi:10.1001/jama.2024.15815

Question and Methods: Multi-centre, randomized control trial to determine whether a high-intensity NIPPV strategy reduces the need for intubation in AECOPD patients compared to a low-intensity NIPPV strategy.
Findings: 7/147(4.8%) patients in the high-intensity compared to 21/153(13.7%) in the low-intensity group met intubation criteria; actual intubation rates were similar (high-intensity 3.4% vs. low-intensity 3.9%)
Limitations: Trial was stopped early due to effect on primary outcome and the COVID-19 pandemic; stringent inclusion/exclusion criteria; and crossover limits assessment of true effect.

Interpretation: Among AECOPD patients requiring NIPPV, starting with standard settings followed by trial of high-intensity treatment prior to intubation may be a reasonable approach in very select patients.

Dr. Nicholas Choi

JC Supervisor: Dr Thiruganasambandamoorthy

For more articles on intubation see this LINK


 

Authors

  • Dr. Nicholas Choi is an FRCPC Emergency Medicine resident at the University of Ottawa.

    View all posts
  • Dr. Hans Rosenberg

    Dr. Rosenberg is an emergency physician at the Ottawa Hospital, associate professor at the University of Ottawa, and Director of the Digital Scholarship and Knowledge Dissemination Program.

    View all posts
  • Dr. Venkatesh Thiruganasambandamoorthy is an attending physician and associate scientist at the Ottawa Hospital and Ottawa Hospital Research Institute with an particular interest in syncope and presyncope care.

    View all posts